Examining bone mineral density in adults with cystic fibrosis
Erişkin Kistik Fibrozisli Bireylerde Kemik Mineral Yoğunluğunun Postür, Solunum Fonksiyonları ve Fonksiyonel Egzersiz Kapasitesi Üzerine Etkisi
This study looks at how cystic fibrosis affects bone health and physical abilities in adults aged 18-45.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06088485 on ClinicalTrials.gov |
What this trial studies
This observational study involves 60 voluntary participants aged 18-45 diagnosed with cystic fibrosis. It aims to assess various functional capacities, including respiratory functions, muscle strength, and postural alignment through a series of tests such as the Shuttle Walking Test and the Modified Medical Research Council Dyspnea Scale. Additionally, demographic information and perceptions of cosmetic deformity will be recorded to understand the impact of cystic fibrosis on bone mineral density and overall physical health.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-45 who have been diagnosed with cystic fibrosis.
Not a fit: Patients who have had recent fractures, spine surgery, or other significant orthopedic or neurological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the relationship between bone mineral density and cystic fibrosis, potentially leading to improved management strategies for affected patients.
How similar studies have performed: While there have been studies on cystic fibrosis and bone health, this specific approach focusing on bone mineral density in this age group is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged between 18-45 who were diagnosed with Cystic Fibrosis Exclusion Criteria: In the last year, patients; * who had a fracture in any part of the patient's body * who had undergone spine surgery * who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis
Where this trial is running
Ankara
- Hacettepe University, Health Sciences Faculty — Ankara, Turkey (Recruiting)
Study contacts
- Principal investigator: Aynur Demirel — Hacettepe University
- Study coordinator: Aynur Demirel, PhD
- Email: aynurdemirel629@hotmail.com
- Phone: 05545295057
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.